Northwestern Mutual Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9	Buy	+8	New	+$9	﹤0.01%	4058
2025 Q4	–	Sell	-1	Closed	-$2	–	4129
2025 Q3	$2	Sell	1 -37	-97%	-$71	﹤0.01%	3786
2025 Q2	$77	Buy	+38	New	+$73	﹤0.01%	3565
2025 Q1	–	Sell	-193	Closed	-$353	–	3803
2024 Q4	$353	Buy	193 +191	+9,550%	+$845	﹤0.01%	3411
2024 Q3	$12	Buy	+2	New	+$16	﹤0.01%	3561
2024 Q2	–	Sell	-30	Closed	-$416	–	3652
2024 Q1	$416	Buy	30 +24	+400%	+$207	﹤0.01%	3326
2023 Q4	$36	Buy	+6	New	+$30	﹤0.01%	3414
2023 Q1	–	Sell	-3	Closed	-$55	–	3482
2022 Q4	$55	Sell	3 -775	-100%	-$17.6K	﹤0.01%	3246
2022 Q3	$16K	Sell	778 -97	-11%	-$2.48K	﹤0.01%	2304
2022 Q2	$18K	Buy	875 +100	+13%	+$2.82K	﹤0.01%	2296
2022 Q1	$33K	Sell	775 -17	-2%	-$766	﹤0.01%	2108
2021 Q4	$47K	Buy	792 +17	+2%	+$1.36K	﹤0.01%	2002
2021 Q3	$67K	Hold	775	–	–	﹤0.01%	1791
2021 Q2	$86K	Hold	775	–	–	﹤0.01%	1658
2021 Q1	$86K	Hold	775	–	–	﹤0.01%	1545
2020 Q4	$82K	Hold	775	–	–	﹤0.01%	1469
2020 Q3	$108K	Sell	775 -83	-10%	-$17.3K	﹤0.01%	1249
2020 Q2	$278K	Buy	858 +4	+0.5%	+$642	﹤0.01%	862
2020 Q1	$76K	Buy	854 +79	+10%	+$4.87K	﹤0.01%	1212
2019 Q4	$31K	Hold	775	–	–	﹤0.01%	1608
2019 Q3	$19K	Hold	775	–	–	﹤0.01%	1748
2019 Q2	$27K	Hold	775	–	–	﹤0.01%	1607
2019 Q1	$35K	Hold	775	–	–	﹤0.01%	1511
2018 Q4	$37K	Hold	775	–	–	﹤0.01%	1360
2018 Q3	$52K	Sell	775 -1,042	-57%	-$58K	﹤0.01%	1304
2018 Q2	$85K	Hold	1,817	–	–	﹤0.01%	1049
2018 Q1	$103K	Hold	1,817	–	–	﹤0.01%	948
2017 Q4	$90K	Hold	1,817	–	–	﹤0.01%	956
2017 Q3	$138K	Hold	1,817	–	–	﹤0.01%	805
2017 Q2	$171K	Buy	+1,817	New	+$155K	﹤0.01%	720

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's INO Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 8 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #4058 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in INO as recently as Q3 2025.

Northwestern Mutual Wealth Management first reported a position in INO in Q2 2017 and has held it in 30 quarters since. The position peaked at $278K in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Northwestern Mutual Wealth Management held 8 shares of Inovio Pharmaceuticals worth $9 as of Q2 2026.
Inovio Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4058 holding.
Northwestern Mutual Wealth Management first reported a position in Inovio Pharmaceuticals in Q2 2017 and has held it in 30 quarters since.
Northwestern Mutual Wealth Management's Inovio Pharmaceuticals position peaked at $278K in Q2 2020.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.